Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe

Assessments of clinical evidence vary between regulators and health technology assessment bodies, but precise differences remain unclear. To compare uncertainties raised on the clinical evidence of approved drugs, we analyzed assessments of regulators and health technology assessment (HTA) bodies in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Pharmacol Ther
Hauptverfasser: Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G. M., Kesselheim, Aaron S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7484915/
https://ncbi.nlm.nih.gov/pubmed/32236959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1835
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge